Sign in
Taking people in United StatesPhase 4

Longer versus shorter Clomid treatment before IVF in women with low egg supply

Compares longer and shorter Clomid use for ovarian stimulation in women with diminished ovarian reserve.

Key facts

Who runs it
University of Southern California
Where
Pasadena, United StatesSee the site
Trial code
Registry title
Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation
Status
Recruiting
Phase
Phase 4
People taking part
120 people, planned
Started
1 Jun 2025
Expected to end
Jun 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Clomiphene Citrate
Record updated
4 August 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women with low egg reserve in the ovaries (diminished ovarian reserve) who are having IVF. It compares a long Clomid schedule with a 5-day Clomid schedule.

Age
18 to 44 years; the woman must be under 45 when stimulation starts.
Sex
Women only.
Disease stage
Female infertility with diminished ovarian reserve, meeting the POSEIDON criteria based on clinic evaluation. The woman must be undergoing IVF and planning a 36-hour trigger window. She must plan to freeze all embryos, or have a fresh transfer if placed in the short Clomid group.
Earlier treatment
People who had an egg released too early (premature ovulation) in the past cannot join.
Biomarker or test result
Antral follicle count (small follicles seen on ultrasound) of 2 or more. The male partner or sperm source cannot be azoospermic (no sperm in the semen).

Main reasons for not taking part

  • Normal ovarian reserve or a good response to stimulation
  • Allergy or bad reaction to Clomid
  • Minimal stimulation protocols
  • Past premature ovulation

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Undergoing IVF
  • Must meet POSEIDON criteria based on clinic evaluation
  • Female partner: Antral follicle count of 2 or more and age <45 at time of stimulation start
  • Male partner/sperm source: Cannot be azoospermic
  • Planning freeze-all cycle (regardless of blastocyst or cleavage stage culture) or fresh transfer if randomized to short Clomid group
  • Planning 36-hour trigger window

Who cannot take part

  • History of prior premature ovulation
  • Allergy or adverse reaction to Clomid
  • Normal ovarian reserve or good response
  • Minimal stimulation protocols

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 44 years old?

Where in United States

  • HRC FertilityPasadena, United StatesContact: Bonnie Song, MDTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to evaluate a long Clomid protocol as compared to a 5-day Clomid protocol for ovarian stimulation in patients with diminished ovarian reserve undergoing ovarian stimulation for in-vitro fertilization. The aim of the long Clomid protocol is to intensify stimulation of the ovaries and reduce both cost and injection burden for patients. Participants will be randomized to receive the long Clomid protocol vs. the typical protocol involving Clomid only for 5 days followed by growth hormone-releasing hormone (GnRH) antagonist. The primary outcome the investigators will evaluate will be the number of mature eggs retrieved.

The 2 groups in the trial

  • Long ClomidTreatment being tested

    Clomid with gonadotropins throughout the entire duration of ovarian stimulation without addition of GnRH antagonist

    Treatment: Clomiphene Citrate

  • 5-day ClomidExisting treatment, for comparison

    Clomid only for 5 days at beginning of ovarian stimulation with gonadotropins, with GnRH antagonist added when the lead follicle reaches \~14mm.

    Treatment: Clomiphene Citrate

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Evaluation of a Long Versus Short Clomid Protocol for Controlled Ovarian Stimulation in Patients With Diminished Ovarian Reserve Undergoing In-vitro Fertilization: a Randomized Controlled Trial
Plain-language title
Longer versus shorter Clomid treatment before IVF in women with low egg supplyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Fit questions
Built from NCT06701071, who can take part
Record updated
4 August 2026